341607
FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074
1-t-Butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)-pyrido[2,3-d]pyrimidin-7-yl)urea, PD173074
請聯絡客服人員
台灣默克股份有限公司
內湖區堤頂大道二段89號6樓
11493 台北
台灣
電話: +886-2-21621111
傳真: +886-2-87516262
電子郵件: eShop.MTAW@merckgroup.com
13 二月 2012
請稍候
A cell-permeable pyridopyrimidine compound that acts as a potent, ATP-competitive, and reversible inhibitor of FGF and VEGF receptors (IC50 = 21.5 nM for FGFR1). It inhibits PDGFR and c-Src only at much higher concentration (IC50 = 17.6 µM, 19.8 µM, respectively) and exhibits little effect against EGFR, InsR, MEK, and cPKC even at concentrations as high as 50 µM. Shown to inhibit the autophosphorylation of endogenous FGFR1 (IC50 <5 nM) and overexpressed VEGFR2 (IC50 <200 nM) in NIH3T3 cells in vitro, and FGF- and VEGF-induced angiogenesis in mice in vivo.
| 產品資訊 | |||
|---|---|---|---|
| Form | Yellow solid | ||
| Protect from Light | 是 | ||
| Packaged under inert gas | 是 | ||
| Purity | ≥97% by HPLC | ||
| Chemical formula | C28H41N7O3 | ||
| CAS number | 219580-11-7 | ||
| 儲存和運送資訊 | |||
|---|---|---|---|
| Storage | +2°C to +8°C | ||
| Ship |
Ambient Temperature Only
Irritant |
||
